The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis, as the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to its new artificial intelligence-powered companion diagnostic device, the VENTANA® TROP2 (EPR20043) RxDx.
Patchy progress means many millions of people are still impacted by lung conditions and unaware of the risks that exist in their everyday lives. Dr Andy Whittamore, Clinical Lead at Asthma + Lung UK, discusses the multitude of risk factors impacting the nation’s lung health and provides health advice to mitigate those risks.
Advertisements
Latest Academic Articles
The latest academic articles from key research stakeholders
